Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats
Authors:
- 1 March 2012
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 62 (3) , 1422-1431
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in ratsEuropean Journal of Pharmacology, 2010
- Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced By Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in SchizophreniaBiological Psychiatry, 2010
- Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatmentPharmacology Biochemistry and Behavior, 2009
- Parvalbumin neurons and gamma rhythms enhance cortical circuit performanceNature, 2009
- Driving fast-spiking cells induces gamma rhythm and controls sensory responsesNature, 2009
- Prolonged Exposure to NMDAR Antagonist Suppresses Inhibitory Synaptic Transmission in Prefrontal CortexJournal of Neurophysiology, 2008
- Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administrationPsychopharmacology, 2008
- Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self‐administration and after extinction in ratsJournal of Neurochemistry, 2008
- NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal NeuronsThe Journal of Neuroscience, 2007
- Comparative genome‐ and proteome analysis of cerebral cortex from MK‐801‐treated ratsJournal of Neuroscience Research, 2002